SCHEMBL29328556

SCHEMBL29328556

COC(=O)c1ccc(-c2cn3nccc3c(O)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.50
ALDH1A3 P47895 2/20 0.50
MAPT P10636 7/20 0.49
GAA P10253 2/20 0.49
ALDH1A2 O94788 1/20 0.47
TLR8 Q9NR97 1/20 0.45
KDM4E B2RXH2 6/20 0.44
KMT2A Q03164 2/20 0.44
LMNA P02545 2/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 6/20 0.43
RAB9A P51151 6/20 0.43
GLA P06280 1/20 0.43
HPGD P15428 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
HSD17B10 Q99714 2/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24742061 0.78 MEN1 (0.38) ALDH1A1MAPTGAAKDM4EKMT2A
SCHEMBL19434406 0.70 F2RL3 (0.50) ALDH1A1ALDH1A3MAPTGAAALDH1A2
SCHEMBL32664232 0.70 MAPK14 (0.44) ALDH1A1MAPTGAAKDM4EKMT2A
SCHEMBL25283404 0.69 GAA (0.52) ALDH1A1GAAKDM4EKMT2ASMN1; SMN2
SCHEMBL30079151 0.69 CA1 (0.57) ALDH1A1MAPTGAAKDM4EKMT2A
SCHEMBL28705905 0.68 MEN1 (0.53) ALDH1A1ALDH1A3MAPTGAAKDM4E
SCHEMBL31228042 0.68 ALDH1A1 (0.51) ALDH1A1ALDH1A3MAPTGAAALDH1A2
SCHEMBL1302416 0.68 ALDH1A1 (0.51) ALDH1A1ALDH1A3MAPTALDH1A2TLR8
SCHEMBL11006118 0.68 MAPT (0.56) ALDH1A1ALDH1A3MAPTLMNARAB9A
SCHEMBL8887061 0.67 ALDH1A1 (0.45) ALDH1A1MAPTGAAKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed